Related Experiment Video
Updated: Nov 14, 2025
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano1, George M Savva2, Janis R Bedarf2,3
1Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. stefano.romano@quadram.ac.uk.
Abstract:
The gut microbiota is emerging as an important modulator of neurodegenerative diseases, and accumulating evidence has linked gut microbes to Parkinson's disease (PD) symptomatology and pathophysiology. PD is often preceded by gastrointestinal symptoms and alterations of the enteric nervous system accompany the disease. Several studies have analyzed the gut microbiome in PD, but a consensus on the features of the PD-specific microbiota is missing. Here, we conduct a meta-analysis re-analyzing the ten currently available 16S microbiome datasets to investigate whether common alterations in the gut microbiota of PD patients exist across cohorts. We found significant alterations in the PD-associated microbiome, which are robust to study-specific technical heterogeneities, although differences in microbiome structure between PD and controls are small. Enrichment of the genera Lactobacillus, Akkermansia, and Bifidobacterium and depletion of bacteria belonging to the Lachnospiraceae family and the Faecalibacterium genus, both important short-chain fatty acids producers, emerged as the most consistent PD gut microbiome alterations. This dysbiosis might result in a pro-inflammatory status which could be linked to the recurrent gastrointestinal symptoms affecting PD patients.
Insights
This meta-analysis reveals consistent gut microbiome alterations in Parkinson's disease (PD) patients, including specific beneficial bacteria enrichment and short-chain fatty acid producer depletion, potentially driving inflammation and symptoms.
Area of Science:
- Microbiology
- Neuroscience
- Gastroenterology
Background:
- The gut microbiota plays a role in neurodegenerative diseases.
- Parkinson's disease (PD) is linked to gut microbiome alterations and gastrointestinal issues.
- A consensus on PD-specific gut microbial features is lacking.
Purpose of the Study:
- To conduct a meta-analysis of 16S microbiome datasets to identify common gut microbiota alterations in PD patients.
- To investigate if PD-associated gut microbiome changes are consistent across different studies.
Main Methods:
- Meta-analysis of ten existing 16S rRNA gene sequencing datasets from PD patients and controls.
- Statistical analysis to identify robust alterations in gut microbial composition.
- Comparison of microbiome structures between PD and control cohorts.
Main Results:
- Consistent alterations in the gut microbiota of PD patients were identified across cohorts.
- Enrichment of Lactobacillus, Akkermansia, and Bifidobacterium genera observed.
- Depletion of Lachnospiraceae family and Faecalibacterium genus, key short-chain fatty acid producers, noted.
- Small but significant differences in overall microbiome structure between PD and controls.
Conclusions:
- A common PD-associated gut dysbiosis exists, characterized by specific microbial shifts.
- This dysbiosis may contribute to a pro-inflammatory state.
- The identified gut microbiome alterations could be linked to gastrointestinal symptoms in PD patients.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:23Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
01:29Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...